We're hiring! Fantastic opportunity to work with @JoeCursons and our Computational Biology and Bioinformatics team to support our IO target discovery efforts. Applications close Monday 2 November 2020, 11:55pm AEDT.
We're looking for a highly skilled Senior Scientist to join our brilliant Functional Genomics & Screening Team. If this could be you, please respond to KSC 5-11 by Sunday 4 October 11:55pm AEDT.
Momentum is building in the allogenic CAR cell therapy space with CAR NK cells receiving a lot of attention @GileadSciences @KitePharma CSO comments on NK cell therapies in cancer via their partnership with @oNKo_innate
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
